CD3-positive large B-cell lymphoma

American Journal of Surgical Pathology

Volumn 33, Issue 4, 2009, Pages 505-512

  Wang, Jun ^a   Chen, Chen ^b   Lau, Sean ^c   Raghavan, Ravi I ^a   Rowsell, Edward H ^a   Said, Jonathan ^b   Weiss, Lawrence M ^c   Huang, Qin ^c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CD3; Immunohistochemistry; Large B cell; Lymphoma

Indexed keywords

CD3 ANTIGEN; DNA; RIBOSOME PROTEIN; RNA BINDING PROTEIN; RPL22 PROTEIN, HUMAN; TUMOR MARKER; VIRUS RNA;

ADULT; AGED; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; B LYMPHOCYTE; CELL CLONE; CHEMISTRY; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; GENETICS; IMMUNOGLOBULIN GENE; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED, 80 AND OVER; ANTIGENS, CD3; B-LYMPHOCYTES; CLONE CELLS; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RIBOSOMAL PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 63849255039     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318185d231     Document Type: Article

References (54)

1. Aboulafia D, Gown AM, Kidd P. AISD-associated B-cell non-Hodgkin's lymphoma masquerading as a cutaneous T-cell neoplasm: an aberrant immunophenotype requiring comprehensive analysis for lineage resolution. Am J Dermatopathol. 1997;19:66-72.
2. Aisenberg AC, Bloch KJ, Wilkes BM. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets. J Exp Med. 1981;154:1709-1714.
3. Algino KM, Thomason RW, King DE, et al. CD20 (pan-B cell antigen) expression on bone marrow derived T cells. Am J Clin Pathol. 1996;106:76-81.
4. Antin JH, Emerson SG, Martin P, et al. Leu-1+ (CD5+) B cells: a major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol. 1986;136:505-510.
5. Arber DA, Weiss LM. CD43: a review. Appl Immunohistochem. 1993;1:88-96.
6. Arber DA, Weiss LM. CD5: a review. Appl Immunohistochem. 1995;3:1-22.
7. Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med. 1993;328:1023-1030.
8. Brohee D, Cuuchie P, Neve P. Co-expression of CD2 or CD8 antigens in B-cell chronic lymphocytic leukemia. A flow cytometry analysis of 3 cases. Acta Clinica Belgica. 1994;49:183-186.
9. Burns GF, Nash AA, Norman CP, et al. A human leukemic cell expressing hybrid membrane phenotypes. Nature. 1977;267: 243-245.
10. Campana D, Thompson JS, Amlot P, et al. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol. 1987;138:648-655.
11. Chang KL, Chen YY, Shibata D, et al. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
12. Chetty R, Gatter K. CD3: structure, function, and role of immunostaining in clinical practice. J Pathol. 1994;173:303-307.
13. Clevers H, Dunlap S, Terhorst C. The transmembrane orientation of the epsilon chain of the TCR/CD3 complex. Eur J Immunol. 1988; 18:705-710.
14. Clevers H, Alarcon B, Wileman T, et al. The T cell receptor/CD3 complex: a dynamic protein ensemble. Ann Rev of Immunol. 1988; 6:629-662.
15. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449:473-477.
16. Daibata M, Taguchi T, Nemoto Y, et al. Epstein-Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a now CD2-positive PAL B-cell line. Br J Haematol. 2002;117:547-557.
17. Dennings SM, Tuck DT, singer KH, et al. Activation of human thymocytes via CD3 and CD2 molecules. In: McMichael AJ, ed. Leukocyte Typing III, White Cell Differentiation Antigens. Oxford, New York; Tokyo; Oxford, UK: Oxford University Press; 1987:144-147.
18. DiGuiseppe JA, Borowitz MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol. 1998;25:6-10.
19. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433-5439.
20. Foan KA, Bitting RJ, Terasaki PI. Dual B and T markers in chronic lymphocytic leukemia. Blood. 1980;55:16-20.
21. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe E, Harris N, Stein H, et al, eds. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2001:171-174.
22. Greiner TC, Raffeld M, Lutz C, et al. Analysis of T cell receptor-g gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. Am J Pathol. 1995;146:46-55.
23. Grumayer ER, Griesinger F, Hummell DS, et al. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7. Blood. 1991;77:64-68.
24. Gulley LG, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMP-1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002;117:259-267.
25. Hamilton-Dutoit SJ, Pallesen G. B cell associated monoclonal antibody L26 may occasionally label T cell lymphomas. APMIS. 1989;97:1033-1036.
26. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
27. Hoffmann DG, Tucker SJ, Emmanoulides C, et al. CD8-positive mantle cell lymphoma: a report of two cases. Am J Clin Pathol. 1998;109:689-694.
28. Hsu CCS, Marti GE, Schrek R, et al. Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia. Clin Immunol Immunopathol. 1975;3:385-395.
29. Huang Q, Chang KL, Gaal KK, et al. KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. Am J Surg Pathol. 2004;28:693-697.
30. Hultin LE, Hausner MA, Hultin MA, et al. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry. 1993;14:196-204.
31. Inaba T, Shimazaki C, Sumikuma T, et al. T-cell associated antigen-positive B-cell lymphoma. Leuk Lymphoma. 2001;42:1161-1171.
32. Kantor AB. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today. 1991;12:389-391.
33. Khalidi HS, Brynes RK, Borwne P, et al. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. Mod Pathol. 1998;11:983-988.
34. Kipps TJ. The CD5 B cell. Adv Immunol. 1989;47:117-185.
35. Kume M, Suzuki R, Yatabe Y, et al. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Jpn J Cancer Res. 1997;88:1087-1093.
36. Kurtin PJ, Hobday KS, Ziesmer S, et al. Demonstration of distinct antigen profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Pathol. 1999;112:319-329.
37. Linder J, Ye Y, Armitage JO, et al. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin embedded tissues. Mod Pathol. 1988;1:29-34.
38. Mason DY, Cordell J, Brown M, et al. Detection of T cell in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol. 1989;42:1194-1200.
39. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207-216.
40. Mohrmann RL, Arber DA. CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mod Pathol. 2000;13:1244-1252.
41. Noguchi M, Sakamoto N, Okumura H, et al. CD8-positive diffuse large B-cell lymphoma. Rinsko Ketsueki. 2000;41:591-595 (in Japanese).
42. Norton AJ, Isaacson PG. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. J Clin Pathol. 1987;40:1405-1412.
43. Ozdemirli M, Cheson B, Jaffe ES. What is anaplastic large cell lymphoma? [letter] Am J Surg Pathol. 2004;28:1664-1665.
44. Pallesen G. Immunohistological analysis of tissue specificity of the 52 workshop anti-B lymphocyte monoclonal antibodies. Cancer Rev. 1988;8:277-288.
45. Quintanilla-Martinez L, Preffer F, Rubin D, et al. CD20+ T cell lymphoma: neoplastic transformation of a normal T-cell subset. Am J Clin Pathol. 1994;102:483-489.
46. Segal GH, Jorgensen T, Masih AS, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol. 1994;25: 1269-1275.
47. Segal GH, Jorgensen T, Scott M, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. follicular lymphomas. Hum Pathol. 1994;25:1276-1282.
48. Swerdlow SH. Small B-cell lymphomas of the lymph nodes and spleen: practical insights to diagnosis and pathogenesis. Mod Pathol. 1999;12:125-140.
49. Takami A, Saito M, Nakao S, et al. CD20-positive T-cell chronic lymphocytic leukemia. Br J Haematol. 1998;102:1327-1329.
50. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood. 1998;91:1145-1151.
51. Tiesinga JJ, Wu D, Inghirami G. CD5+ follicular center lymphoma: immunophenotyping detects a unique subset of ''floral'' follicular lymphoma. Am J Clin Pathol. 2000;114:912-921.
52. Toyama T, Kubuki Y, Sasaki H, et al. Primary splenic CD8-positive diffuse large B-cell lymphoma. Rinsho Ketsueki. 2001;42:1187-1191 (in Japanese).
53. Uckun FM, Muraguchi A, Ledbetter JA, et al. Biphenotypic leukemic lymphocyte precursors in CD2+ CD19+ acute lympho-blastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood. 1989;73:1000-1015.
54. Warzynski JJ, Graham DM, Axtell RA, et al. Low level CD20 expression on T cell malignancies. Cytometry. 1994;18:88-92.